Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.

Circulation Research
Jesus A AraujoAndre E Nel

Abstract

Air pollution is associated with significant adverse health effects, including increased cardiovascular morbidity and mortality. Exposure to particulate matter with an aerodynamic diameter of <2.5 microm (PM(2.5)) increases ischemic cardiovascular events and promotes atherosclerosis. Moreover, there is increasing evidence that the smallest pollutant particles pose the greatest danger because of their high content of organic chemicals and prooxidative potential. To test this hypothesis, we compared the proatherogenic effects of ambient particles of <0.18 microm (ultrafine particles) with particles of <2.5 microm in genetically susceptible (apolipoprotein E-deficient) mice. These animals were exposed to concentrated ultrafine particles, concentrated particles of <2.5 microm, or filtered air in a mobile animal facility close to a Los Angeles freeway. Ultrafine particle-exposed mice exhibited significantly larger early atherosclerotic lesions than mice exposed to PM(2.5) or filtered air. Exposure to ultrafine particles also resulted in an inhibition of the antiinflammatory capacity of plasma high-density lipoprotein and greater systemic oxidative stress as evidenced by a significant increase in hepatic malondialdehyde levels and up...Continue Reading

References

Nov 5, 1998·The Journal of Allergy and Clinical Immunology·A E NelA Saxon
Dec 15, 2000·The New England Journal of Medicine·J M SametS L Zeger
Mar 23, 2001·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·M J Utell, M W Frampton
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·A NemmarB Nemery
Mar 7, 2002·JAMA : the Journal of the American Medical Association·C Arden PopeGeorge D Thurston
Mar 19, 2002·Journal of the American College of Cardiology·Tatsushi SuwaStephan F van Eeden
Apr 5, 2003·Environmental Health Perspectives·Ning LiAndre Nel
Oct 16, 2004·Circulation Research·Philip J BarterAlan M Fogelman
Feb 3, 2005·Environmental Health Perspectives·Nino KünzliHoward N Hodis
Jul 19, 2005·Journal of Toxicology and Environmental Health. Part a·Francesca DominiciJonathan M Samet
Jul 23, 2005·Inhalation Toxicology·Michael J OldhamMichael T Kleinman
Nov 2, 2005·Journal of the Air & Waste Management Association·Michael T KleinmanArthur K Cho
Jan 18, 2006·JAMA : the Journal of the American Medical Association·Qinghua SunSanjay Rajagopalan
Feb 4, 2006·Science·Andre NelNing Li
Aug 26, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Peter S GargalovicAldons J Lusis
Oct 13, 2006·European Journal of Clinical Investigation·M GurI Ozdogru
Feb 3, 2007·The New England Journal of Medicine·Kristin A MillerJoel D Kaufman
Jul 20, 2007·Circulation·B HoffmannUNKNOWN Heinz Nixdorf Recall Study Investigative Group

❮ Previous
Next ❯

Citations

Jun 1, 2011·Analytical and Bioanalytical Chemistry·Silvia DiabatéCarsten Weiss
Nov 12, 2009·Environmental Monitoring and Assessment·Shuofei Dong, Maosheng Yao
Apr 16, 2009·Environmental Science and Pollution Research International·Valentina RubioEmilio Rojas
Jul 10, 2010·Current Atherosclerosis Reports·Robert D Brook, Sanjay Rajagopalan
Nov 3, 2011·Chemical Reviews·Renyi ZhangWen Xu
Nov 26, 2008·Nature Clinical Practice. Cardiovascular Medicine·Nicholas L MillsDavid E Newby
Jan 16, 2010·Journal of Toxicology and Environmental Health. Part a·A J LeBlancT R Nurkiewicz
Feb 4, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Daher Ibrahim AiboJack R Harkema
Dec 15, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Lindsay Wichers StanekDaniel L Costa
Aug 30, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Xiaohua XuQinghua Sun
Dec 29, 2010·Journal of Occupational and Environmental Medicine·Mary Berlik RiceDavid Christiani
Jun 17, 2011·Journal of Occupational and Environmental Medicine·Ning Li, Andre E Nel
Dec 23, 2011·Current Opinion in Pulmonary Medicine·Matthew J CampenMichael Rosenfeld
Apr 2, 2010·Journal of the Royal Society, Interface·P BerntsenE H Zhou
Aug 26, 2009·Annual Review of Public Health·Tian XiaAndre E Nel
Dec 18, 2012·American Journal of Physiology. Cell Physiology·Rongsong LiTzung Hsiai
Sep 4, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Sarah MahneKurt J Varner
Jun 19, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Tom W CherngNancy L Kanagy
Jun 5, 2012·Circulation. Heart Failure·Loren E WoldSanjay Rajagopalan
Mar 19, 2011·Circulation Research·Daniel J Conklin
Jun 30, 2010·Circulation·Qinghua SunLoren E Wold
Feb 24, 2009·American Journal of Respiratory and Critical Care Medicine·James M SametRobert B Devlin
Jan 12, 2013·American Journal of Respiratory Cell and Molecular Biology·Rob McConnellScott Fruin
Sep 13, 2013·Environmental Health : a Global Access Science Source·Nithya ElangoJeyanthi Govindasamy Poornima
Dec 18, 2013·Particle and Fibre Toxicology·Mark R MillerPatrick W F Hadoke
Jun 8, 2010·Particle and Fibre Toxicology·Alexandra SchneiderRobert B Devlin
Feb 4, 2010·Environmental Health Perspectives·Ralph J DelfinoConstantinos Sioutas
Oct 22, 2010·Environmental Health Perspectives·Jason D SacksMary Ross
Feb 18, 2010·PloS One·Nino KünzliWendy J Mack
Feb 2, 2011·PloS One·Lotte JacobsTim S Nawrot
Jul 10, 2010·International Journal of Environmental Research and Public Health·Shona C FangDavid C Christiani
Jul 14, 2010·International Journal of Environmental Research and Public Health·Efthimios TagarisArmistead G Russell
Oct 20, 2011·Hämostaseologie·J Emmerechts, M F Hoylaerts

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Journal of the American College of Cardiology
Tatsushi SuwaStephan F van Eeden
The New England Journal of Medicine
Douglas W DockeryF E Speizer
JAMA : the Journal of the American Medical Association
C Arden PopeGeorge D Thurston
© 2021 Meta ULC. All rights reserved